Since Greenphire’s inception, our team has been wholly committed to improving the clinical trial participant journey. Whether that’s transforming how reimbursements are made through ClinCard or putting relevant financial and logistical information in the palm of the participant’s hand through GreenSpace, our solutions aim to remove the burdens which impede the patient experience and hamper recruitment and retention.
In our most recent annual market research survey, it was particularly evident that sponsors across the globe are increasingly committed to “addressing travel and logistical support needs” for clinical trial participants across all therapeutic areas.
Over the past 8 years, Greenphire has continuously invested in our local and long-distance travel solution, ConneX, and from rideshare to white glove service, no provider has facilitated more participant visits.
Our ultimate goal? Serve as the preeminent partner of choice to support the entire continuum of needs throughout the patient journey.
That’s why I’m excited to announce Greenphire’s recent acquisition of Clincierge. By integrating the most advanced and scalable technology with the leading high-touch, service-based approach, Greenphire is now able to provide clients with a single source of globally ready, flexible solutions to meet the unique needs of every trial.
With medicine becoming ever more personalized, each clinical trial participant has an increasingly critical impact. That’s especially true for oncology and rare disease studies, where a high percentage of research is taking place today and where there is an elevated need to ease burden on participants.
The acquisition of Clincierge further strengthens Greenphire’s ability to improve the patient journey for the most complicated and service-intensive trial scenarios, reinforcing our commitment to meet each patient and site where they are.
